繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

周五售前移民者-现代,维珍银河,高盛

2021-10-15 12:22

U.S. stock futures were higher Friday as corporate earnings helped improve sentiment and offset inflation concern.

Here are some of the top movers in premarket trading ahead of the opening bell on Friday.

1. Moderna MRNA | Up 2.5%

Shares of Moderna( MRNA ) - Get Moderna, Inc. Reportadvanced after a U.S. Food and Drug Administration panel gave its approval to a third half-dose booster shot to some Americans to bolster protection against Covid-19.

2. Virgin Galactic SPCE | Down 17%

Shares of Virgin Galactic( SPCE ) - Get Virgin Galactic Reportdropped after the space-tourism company once again delayed the launch of full commercial service for private-astronaut trips, this time until fourth-quarter 2022, as it works to improve its vehicles.

TheStreet Recommends

INVESTING

Premarket Movers Friday - Moderna, Virgin Galactic, Goldman Sachs

2 minutes agoPRESS RELEASES

Outlook On The Plasma Protein Therapeutics Global Market To 2027 - By Type, Application And Geography

9 minutes agoPRESS RELEASES

ECRID, The New Credit Bureau Files New IPO

11 minutes ago

3. Goldman Sachs GS | Up 1.5%

Shares of Goldman Sachs( GS ) - Get Goldman Sachs Group, Inc. (GS) Reportwere rising ahead of the investment bank's third-quarter earnings. A survey of analysts by FactSet produced consensus estimates of earnings of $10.11 a share on revenue of $11.67 billion.

4. Alcoa AA | Up 6.6%

Alcoa( AA ) - Get Alcoa Corp. Reportshares jumped Friday after the aluminum producer posted record third-quarter profit late Thursday, unveiled a new buyback program and declared its first-ever dividend.

Alcoa benefited from higher aluminum and alumina prices and reported a 31% rise in sales for its latest quarter.

5. Duck Creek Technologies DCT | Down 18%

Shares of Duck Creek Technologies( DCT ) - Get DUCK CREEK TECHNOLOGIES, INC. Reportfell after the enterprise software company reported a net loss for the final quarter of its fiscal year.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。